Pangaea Oncology S.A. (MC:PANG) — Stock Price

€1.55 EUR
▲ 0.00% today

Pangaea Oncology S.A. (MC:PANG) is currently trading at €1.55 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €1.50 and €1.75. This page tracks Pangaea Oncology S.A.'s live share price on the MC exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Pangaea Oncology S.A. worth.

Pangaea Oncology S.A. (PANG) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Pangaea Oncology S.A.'s daily closing share price and trading volume on the MC exchange over the past year, giving a clear view of recent price momentum and liquidity.

Pangaea Oncology S.A. Income Statement — Revenue, Profit & Earnings by Year

Pangaea Oncology S.A.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue €14.27 Million €8.00 Million €4.37 Million €4.60 Million €4.10 Million
Cost of Revenue €-21.02K €244.86K €255.54K €-568.61K €-512.72K
Gross Profit €14.29 Million €7.75 Million €4.11 Million €5.17 Million €4.61 Million
Research & Development €1.03 Million
SG&A €4.07 Million €9.17 Million €1.21 Million €761.39K €1.21 Million
Total Operating Expenses €12.23 Million €10.50 Million €6.31 Million €5.47 Million €6.28 Million
Operating Income €2.06 Million €-2.74 Million €2.56 Million €-532.97K €-1.66 Million
EBITDA €1.19 Million €-1.56 Million €-1.41 Million €146.78K €730.31K
EBIT €-1.39 Million €-3.37 Million €-2.65 Million €-845.50K €-1.68 Million
Interest Expense €301.31K €133.94K €189.41K €252.91K €186.03K
Income Before Tax €-1.69 Million €-3.51 Million €-2.84 Million €-1.10 Million €-1.91 Million
Income Tax Expense €-495.65K €1.29 Million €-114.71K €-456.51K €-112.68K
Net Income €-1.17 Million €-4.66 Million €-2.71 Million €-641.91K €-1.79 Million

Pangaea Oncology S.A. Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Pangaea Oncology S.A.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets €32.41 Million €28.83 Million €28.38 Million €20.85 Million €17.17 Million
Total Current Assets €13.12 Million €9.63 Million €13.31 Million €7.52 Million €5.79 Million
Cash & Equivalents €7.10 Million €2.02 Million €251.48K
Short-term Investments €1.10 Million €1.41 Million €1.41 Million €911.32K €48.37K
Net Receivables €7.68 Million €6.03 Million €3.66 Million €3.60 Million €2.84 Million
Inventory €270.64K €283.02K €234.71K €400.76K €427.11K
Property, Plant & Equipment €352.52K €429.41K €553.07K
Goodwill €2.47 Million €3.78 Million €598.84K €48.79K €287.00
Total Liabilities €9.57 Million €10.03 Million €5.30 Million €6.76 Million €8.61 Million
Total Current Liabilities €7.01 Million €7.17 Million €2.72 Million €3.18 Million €4.58 Million
Long-term Debt €1.23 Million €1.93 Million €2.19 Million
Net Debt €2.27 Million €4.35 Million €-3.61 Million €3.34 Million €6.49 Million
Total Stockholder Equity €22.10 Million €17.82 Million €23.08 Million €14.09 Million €8.57 Million
Retained Earnings €-13.32 Million €-11.83 Million €-7.85 Million €-4.49 Million €-3.46 Million

Pangaea Oncology S.A. Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Pangaea Oncology S.A. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow €-4.57 Million €-2.40 Million €-3.68 Million €-2.50 Million €-1.92 Million
Capital Expenditures €519.88K €291.36K €20.09K €29.67K €70.96K
Free Cash Flow €-5.08 Million €-2.69 Million €-3.70 Million €-2.53 Million €-1.99 Million
Investing Cash Flow €-274.64K €-1.58 Million €-745.57K €-797.48K €-190.19K
Financing Cash Flow €6.79 Million €-1.74 Million €9.50 Million €5.08 Million €2.04 Million
Dividends Paid
Stock-Based Compensation
Depreciation €2.58 Million €1.82 Million €1.24 Million €992.28K €2.41 Million
Change in Cash €1.95 Million €-5.72 Million €5.08 Million €1.77 Million €-88.16K

Pangaea Oncology S.A. Earnings History — EPS Actual vs. Analyst Estimates

Track Pangaea Oncology S.A.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Earnings history is not currently available for Pangaea Oncology S.A..